Advertisement
Home Tags Stem Cells

Tag: Stem Cells

Ruxolitinib Best for Glucocorticoid-Refractory, -Dependent GVHD

0

Overall response, failure-free survival, symptom response significantly greater with ruxolitinib versus control therapy

Stem Cell Transplant Reviewed for Peripheral T-Cell Lymphoma

0

Three- and five-year overall survival similar with allogeneic or autologous HSCT, but transplant-related mortality higher with allogeneic HSCT

Gene Therapy Promising for SCID Due to ADA Deficiency

0

High overall, event-free survival seen at 24 and 36 months for severe combined immunodeficiency due to ADA deficiency

Biden Administration Lifts Restrictions on Medical Research Using Fetal Tissues

0

All projects that had been approved before the Trump administration restrictions 'will be reinstated without further review'

Screening

Stem Cell Transplant May Slow Disability in Multiple Sclerosis

0

Long-term outcomes assessed in 210 patients with MS who underwent autologous hematopoietic stem cell transplantation

HealthDay Reports: New Coronavirus Strain More Contagious

Stem Cell Infusions Investigated for Treatment of COVID-19 ARDS

0

Researchers explore possible anti-inflammatory effects of mesenchymal stem cells in COVID-19 acute respiratory distress syndrome

Tool Could Optimize Antibiotic Prescribing for UTI

Sitagliptin Promising Addition for Preventing Acute GVHD

0

Low incidence of grade II to IV acute GVHD seen in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation

Broader Genetic Testing Could ID More Heritable Cancers

ASH: CRISPR-Cas9 Gene Editing Promising in TDT, SCD

0

Total hemoglobin, fetal Hb increased in seven patients with transfusion-dependent ß-thalassemia, three with sickle cell disease

Broader Genetic Testing Could ID More Heritable Cancers

ASH: CRISPR-Cas9 Gene Editing Promising in TDT, SCD

0

Total hemoglobin, fetal Hb increased in five patients with transfusion-dependent ß-thalassemia, two with sickle cell disease

ASH: Stem Cell Transplant Benefits Older Adults With MDS

0

Overall survival, leukemia-free survival higher for patients assigned to allogeneic HCT versus those with no donor